Regencell Bioscience Holdings Limited Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited

RGC

Kedudukan dalam Saham #3386
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Harga Saham
$10.41
Disegerakkan terakhir: 2026-10-20
Modal Pasaran
$5.16B
Perubahan (1 hari)
3.56%
Perubahan (1 tahun)
-35.07%
Negara
HK
Perdagangan Regencell Bioscience Holdings Limited (RGC)

Kategori

Healthcare
Sejarah pecahan saham untuk Regencell Bioscience Holdings Limited (RGC)
Saham Regencell Bioscience Holdings Limited (simbol: RGC) telah mengalami sejumlah 1 pecahan saham.
Pecahan saham terkini berlaku pada Jun 16, 2025.
Satu saham RGC yang dibeli sebelum Jun 16, 2025 kini bersamaan dengan 38 saham RGC.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
2025-06-16 38:1 x38 x38
Pecahan saham untuk syarikat pesaing atau serupa